跳至主要内容
临床试验/NCT00587574
NCT00587574Unknown不适用

Prospective Phase II Study for Assessment of Regulatory Immune Cell Populations After Allogeneic Hematopoietic Stem Cell Transplantation and Immunomodulatory Consequences of Chronic Graft-Versus-Host Disease and Therapy

Medical University of Vienna2 个研究点 分布在 2 个国家目标入组 150 人开始时间: 2007年10月最近更新:
适应症

试验速览

阶段
不适用
入组人数
150
试验地点
2
主要终点
Correlation of perturbed B cell homeostasis with chronic graft-versus-host disease activity of immune system

研究概览

简要总结

Allogeneic hematopoietic cell transplantation offers high cure rates for patients with hematological and oncological diseases. Graft-versus-host disease (attack of donor's white blood cells on patient's tissues) is a serious complication also affecting the patient's immune system. Therefore, patients in the early phase after allogeneic cell transplantation are at high risk for severe infectious complications. So far, no predictive biomarkers for the development of the chronic form of graft-versus-host disease are available. By analysing serially immune cell populations of the peripheral blood we will investigate whether certain subsets of cells are associated with development of chronic graft-versus-host disease. In addition, the patients' immune regeneration will be evaluated by serial analyses of peripheral blood immune cell populations 3 months to 2 years after allogeneic cell transplantation.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Receiving grafts from either HLA-identical sibling donors or HLA-matched unrelated donors
  • Receiving grafts from HLA-mismatched sibling donors or HLA-mismatched unrelated donors
  • Receiving either bone marrow, peripheral blood stem cells or cord blood grafts
  • Alive on day 100 after transplant
  • Age 18 years or above
  • Signed written informed consent

排除标准

  • Lymphocytopenia not allowing immunophenotyping
  • Treatment with rituximab after HSCT until study entry
  • Hepatitis B and C, HIV infection
  • Secondary posttransplant malignancies including EBV-lymphoproliferative disease
  • Karnofsky score of 30 or below
  • Absence of informed consent

结局指标

主要结局

Correlation of perturbed B cell homeostasis with chronic graft-versus-host disease activity of immune system

时间窗: October 2007 until December 2010

次要结局

  • Compare the number of circulating T, DC, NK subsets in patients with and without chronic GVHD to identify their respective role in development and prolongation of chronic GVHD(October 2007 until December 2010)
  • Investigate the impact of different immunosuppressive/immunomodulatory treatments for chronic GVHD on various immune cell populations(October 2007 until December 2010)
  • Compare number of clinically defined bacterial, viral and fungal infectious episodes between patients with and without chronic graft-versus-host disease(October 2007 until December 2010)
  • Difference of time-dependent pattern of immune reconstitution after allogeneic cell transplantation between patients with and without chronic graft-versus-host disease(October 2010 until December 2010)
  • Assess the chimerism of antigen-presenting cells in circulation and tissue specimens and correlate it with occurrence of chronic GVHD(October 2007 until December 2010)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验

已完成
2 期
A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Hematologic Malignancies-Increasing GVT Effects Without Increasing ToxicityHematopoietic and Lymphoid Cell Neoplasm
NCT03032783Sidney Kimmel Cancer Center at Thomas Jefferson University51
Unknown
1 期
Sequential Administration of WJ-MSCs for the Treatment of GvHD Refractory to Second Line TreatmentGraft Versus Host Disease
NCT06304025Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle10
终止
2 期
A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched RelativesHematologic MalignancyLeukemiaALLAcute Myelogenous LeukemiaHodgkin's LymphomaNon-hodgkin's LymphomaMyelomaLymphomaChronic Lymphocytic LeukemiaAcute Lymphoblastic LeukemiaCLLAML
NCT01532635Sidney Kimmel Cancer Center at Thomas Jefferson University4
招募中
2 期
Allo HSCT Using RIC and PTCy for Hematological DiseasesAcute Myelogenous LeukemiaAcute Lymphocytic LeukemiaBiphenotypic Acute LeukemiaUndifferentiated LeukemiaMyelodysplastic SyndromesLeukemia, MyeloidMyelodysplastic Syndrome With Excess Blasts-1Burkitt LymphomaRelapsed T-Cell LymphomaRelapsed Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaMarginal Zone LymphomaMyeloproliferative NeoplasmProlymphocytic LeukemiaChronic Myelogenous LeukemiaFollicular LymphomaMyelofibrosisPlasma Cell Leukemia
NCT05805605Masonic Cancer Center, University of Minnesota56
招募中
2 期
A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) SyndromeImmunodeficiencyHematopoietic Stem Cell Transplantation
NCT05027945National Cancer Institute (NCI)54
Prospective Phase II Study for Assessment of... | 临床试验